Mike Drues and Sean Fenske discuss a pilot the FDA is conducting that would have the agency providing an interactive 510(k) template to submitting firms.
Sean Fenske and Mike Drues discuss a recently released FDA guidance that outlines a specific communication protocol to address certain 483s with the agency.